Edge Advisors’s Core Laboratories CLB Stock Holding History

Edge Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$48K	Hold	387	–	–	﹤0.01%	520
2018 Q1	$41K	Hold	387	–	–	﹤0.01%	551
2017 Q4	$42K	Buy	387 +70	+22%	+$6.99K	﹤0.01%	542
2017 Q3	$31K	Buy	317 +54	+21%	+$5.24K	﹤0.01%	585
2017 Q2	$26K	Buy	263 +116	+79%	+$12.5K	﹤0.01%	619
2017 Q1	$16K	Buy	+147	New	+$17.1K	﹤0.01%	700

Other funds holding CLB

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Edge Advisors's CLB Position: Q2 2018 in Review

Edge Advisors held its Core Laboratories (CLB) position steady in Q2 2018 at 387 shares worth $48K. The position accounts for ﹤0.01% of the portfolio, ranked #520.

Edge Advisors first reported a position in CLB in Q1 2017 and has held it in 6 quarters since. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.

Edge Advisors held 387 shares of Core Laboratories worth $48K as of Q2 2018.
Edge Advisors left its Core Laboratories share count unchanged in Q2 2018.
Core Laboratories made up ﹤0.01% of Edge Advisors's portfolio in Q2 2018, its #520 holding.
Edge Advisors first reported a position in Core Laboratories in Q1 2017 and has held it in 6 quarters since.
374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.